| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 564.529 | 543.513 | 502.194 | 701.973 | 260.005 | 693.866 | 366.657 | 409.742 | 364.781 | 313.067 |
| Total Income - EUR | 571.569 | 543.599 | 505.719 | 706.772 | 262.020 | 695.333 | 367.093 | 412.033 | 365.862 | 315.215 |
| Total Expenses - EUR | 451.825 | 410.778 | 392.578 | 506.655 | 278.352 | 606.049 | 339.137 | 351.037 | 286.313 | 235.480 |
| Gross Profit/Loss - EUR | 119.744 | 132.822 | 113.141 | 200.116 | -16.332 | 89.284 | 27.956 | 60.995 | 79.550 | 79.735 |
| Net Profit/Loss - EUR | 97.459 | 113.425 | 96.332 | 193.046 | -18.948 | 82.893 | 24.727 | 57.112 | 76.516 | 72.344 |
| Employees | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Pharmasave S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 38.171 | 38.556 | 61.199 | 110.709 | 81.745 | 48.533 | 68.070 | 109.929 | 147.501 | 162.173 |
| Current Assets | 245.525 | 252.826 | 199.719 | 174.969 | 131.017 | 150.675 | 122.674 | 111.222 | 124.498 | 80.874 |
| Inventories | 39.446 | 37.871 | 54.710 | 73.611 | 43.704 | 66.178 | 51.955 | 48.220 | 27.670 | 30.472 |
| Receivables | 89.521 | 66.162 | 120.938 | 55.195 | 37.469 | 32.596 | 33.099 | 46.254 | 81.887 | 27.699 |
| Cash | 116.558 | 148.792 | 24.071 | 46.163 | 49.843 | 51.900 | 37.620 | 16.748 | 14.942 | 22.703 |
| Shareholders Funds | 189.038 | 113.662 | 96.385 | 193.097 | 65.044 | 82.942 | 105.830 | 57.160 | 133.503 | 148.481 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 94.658 | 177.719 | 164.533 | 92.581 | 147.718 | 116.265 | 84.914 | 163.991 | 150.055 | 101.415 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Pharmasave S.r.l.